UPDATE: On December 23rd Health Canada authorized the use of the Moderna vaccine in the fight against COVID-19 for individuals of 18 years of age and older.
JDRF welcomes the authorization of the first COVID-19 vaccine by Health Canada, which we hope will be one of many to be approved in the coming months to address the pandemic. We are grateful for the unprecedented effort by the many research scientists, clinical trial participants, industry partners and government officials who contributed to global efforts to rapidly bring COVID-19 vaccines through the pipeline and to our communities.
The one vaccine approved thus far in Canada is the Pfizer-BioNTech vaccine, which has been approved for use in people aged 16 and over. The vaccine will be given in two doses, at least three weeks apart. Vaccinations have now begun in Canada, with vaccine roll-out plans still evolving. It is currently unclear whether and when people with diabetes may be prioritized for receiving the vaccine. However, JDRF will be advocating on behalf of the T1D community, making it clear to decision-makers that those living with diabetes must be included as a priority group to receive early COVID-19 vaccinations. Evidence does suggest that those living with diabetes, T1D or T2D, could face more severe disease and an increased risk of COVID-19 complications if they develop the disease. As such, JDRF strongly believes this group should be considered a high-risk population and have earlier and easier access to the vaccine. We will keep our T1D community up-to-date as further decisions are made around vaccine roll-out and administration.
Should I get the COVID-19 vaccine if I live with T1D?
Vaccination will not be mandatory in Canada. However, for people living with diabetes, we encourage you to receive the vaccine when you are offered one, pending consultation with your doctor about your individual circumstances. This is because adults, especially older adults, with diabetes (type 1 or type 2) are at risk of developing severe illness if they do get COVID-19, and vaccines are the most effective way to prevent that from happening.
Is the vaccine safe for people with T1D?
Thus far, the Pfizer-BioNTech vaccine is the only COVID-19 vaccine approved in Canada. Trials of this vaccine included people with diabetes, and the data to date show the vaccine is safe and effective for people with T1D.
Health Canada has issued specific guidance on the Pfizer-BioNTech vaccine for people with serious allergies.
Will the vaccine work just as well in people with diabetes?
People with T1D are not immunocompromised, and previous research indicates that the immune response to fighting coronavirus in people with diabetes is no different to people without the condition. In addition, data on the Pfizer-BioNTech vaccine made available by the US FDA indicate that the vaccine is just as effective in people with diabetes as without. However, there is still uncertainty about the length of protection any of the vaccines will provide.
For further information about the availability of COVID-19 vaccination in your community, refer to your Provincial or Territorial Health Authority. As well, please be sure to speak with your healthcare provider with any further questions you may have and to help you make the most informed decision around vaccination.
It’s been just over a year since the virus SARS-CoV-2, which causes the disease COVID-19, was identified.
The COVID-19 pandemic was declared in March 2020. As knowledge about the effects on people with type 1 diabetes (T1D) grew, we updated our information on a dedicated page and in numerous blogs. Unfortunately, most areas of Canada (with the exception of the Atlantic provinces) are deep into the second wave, and many communities are back in some form of modified lockdown.
However, there has recently been reason to have optimism as a number of COVID-19 vaccine candidates have been identified. The UK has already begun its vaccination program.
As of December 2020, Canada had sources more potential vaccine doses per capita than any other country in the world, and as of December 14, 2020, a selected few began to receive their inoculations, although most will be vaccinated in 2021.
As we head into the winter and the cold settles upon us, social opportunities that could take place outside will be limited – and many of us will again begin to feel the strain of isolation. Combine this with living with T1D and the everyday burden of maintaining healthy blood glucose levels, hydration and nutrition throughout the holiday season, when outdoor activities aren’t as accessible.
It’s a lot – and it’s understandable if COVID fatigue is starting to set in. Protecting yourself from the virus on top of everyday diabetes management is a lot to deal with.
Fortunately, we are now better equipped with knowledge of how the virus works and how to best protext ourselves from contracting it. And there is hope on the horizon.
What we know now
How it’s most likely transmitted
At the beginning of the pandemic, it wasn’t immediately clear how COVID-19 was spread, or how contagious the virus was. We didn’t know if was spread by ‘fomites’ (virus particles that remain on surfaces), droplets (from sneezing and coughing) or aerosols (meaning it spreads through the air and can be passed on by an infected person through talking or breathing).
We now know that fomites are not a likely source of virus spread – but that the virus itself is highly contagious and infectious. And that it can be spread via both droplets and aerosols.
Initial advice about protecting yourself and others still stands. Being diligent about frequent handwashing and trying not to touch your face remains true today. The best measures people can take are practicing hand and respiratory hygiene, physical distancing, wearing a face covering, sanitizing high touch surfaces and keeping social contacts limited.
Are people with T1D at greater risk of contracting the virus that causes COVID-19?
There is still no evidence that people with T1D are at any increased risk of being infected by SARS-CoV-2 than anyone else in the community. At the beginning of the pandemic, there may have been higher infection rates among the diabetes community as they had more healthcare contacts.
Are people with T1D at a greater risk if they do develop COVID-19?
People with T1D do not generally have a compromised immune system. However, they may be at higher risk of complications if they do become infected, especially if they are older or have other risk factors, such as kidney disease.
There is no new evidence to indicate that children or young adults with T1D are, on average, at increased risk of complications of COVID-19 if they develop the disease. However, as with any viral infection, blood glucose can be much more difficult to manage, meaning that extra glucose and ketone monitoring is advised for anyone with T1D who develops COVID-19.
Can COVID-19 cause T1D?
A small number of case reports have proposed that COVID-19 can cause diabetes in selected individuals. However, most larger studies do not support this finding. Thus, to date, there is no compelling evidence that COVID-19 can cause T1D. Some effects of the pandemic – such as changes in exposure to the usual, seasonal viruses due to public health restrictions and wearing masks – could potentially affect incidence rates of T1D in the future.
Are COVID-19 vaccines safe for people living with T1D?
The Pfizer and Moderna COVID-19 vaccines use new and cutting-edge technology – known as mRNA vaccines. This is different from other vaccines you get from your doctor, like the MMR or flu inoculation, most of which use an attenuated (or ‘weakened’) form of the virus to trigger an immune response in the body.
These new vaccines work by injecting genetic material called mRNA (messenger RNA) into the body. The mRNA carries instructions that direct the body make the “spike” protein found on the outer surface of the coronavirus (the red edges poking out the ball), and in turn generates a protective response against it – or to the coronavirus, if you should later be exposed to it.
There is no information to date to suggest that the COVID-19 vaccine would not be safe for people with T1D, should they choose to receive it. Generally, people with diabetes have been prioritized for vaccines for infectious diseases, such as the flu.
This information should not be taken as medical advice. Every individual is different and will have unique healthcare needs. Speak to your primary care physician and endocrinologist to come up with the treatment plan that works best for you or your child with T1D.
What you can do now
Stick to the basics
The basics are still the best way to keep yourself and your family safe.
Try to find time for hobbies, books, movies and games that bring you joy and relaxation. Turning off devices and taking a break from news can also help. Filling your time with activities that bring you satisfaction and fulfillment can help ease some of boredom and isolation that may occur over the winter months.
How to get support
JDRF offers a series of virtual events and seminars to help foster connection to other members of the T1D community. Our Let’s Talk T1D Education and Connection series are held monthly to bring people together to discuss issues important to families living with T1D and provide the opportunity for social engagement. These series are meant to both educate and help ease potential loneliness and isolation. Both are offered in both English and French.
The COVID-19 pandemic has been a time of incredible emotional and physical strain. The burden has been even greater for those with T1D. But there is light at the end of the tunnel. With each day that passes, we get one day closer to our new normal.
If you don’t already, please follow us on our social media platforms, where we post tips and articles of interest and encourage you to engage and provide feedback.
To mark November’s National Diabetes Awareness Month, JDRF is excited to announce a new investment of $6 million to support two Canadian research teams as part of the JDRF-CIHR Partnership to Defeat Diabetes to help accelerate development of stem cell-based therapies for type 1 diabetes (T1D).
These new studies make possible the reality of eliminating the need for insulin injections for those living with T1D. There are more than 300,000 Canadians living with T1D, an autoimmune disease with no known cause or cure, resulting in the dysfunction, damage or loss of pancreatic beta cells that produce insulin in our bodies. People with T1D must treat themselves with insulin several times per day to keep their blood glucose levels normal and despite their best efforts; they often experience serious and even life-threatening complications.
Stem cells show great promise as a source of insulin-producing cells that could be transplanted to provide a new source of insulin that replaces dysfunctional, damaged or lost pancreatic beta cells. Canada has a remarkable legacy leading discoveries in this area. Stem cells were discovered in Toronto in 1961; and in 2000 a team in Edmonton pioneered a protocol for transplantation of pancreatic islets (the part of the pancreas that contains insulin-producing cells) that produces insulin independently in many patients who undergo the procedure. These achievements represent important steps toward a treatment that will allow people with T1D to live healthy lives without daily insulin injections.
The two research teams are being led by Dr. Maria Cristina Nostro, Senior Scientist at the McEwen Stem Cell Institute at University Health Network and Associate Professor at the University of Toronto, and Dr. Francis Lynn, Associate Professor with the Faculty of Medicine at the University of British Columbia and an Investigator at BC Children’s Hospital. These teams will build on Canada’s demonstrated research excellence and leadership in clinical islet transplantation, stem cell biology, diabetes, immunology and genetic engineering to accelerate stem cell-based therapies for T1D. Teams will work in collaboration with other Canadian researchers to tackle some of the biggest scientific challenges that impede our progress in this area and move us closer to a future where people with T1D no longer rely on insulin therapy.
Dr. Maria Cristina Nostro’s Research Team
Islet transplantation could help T1D patients regain control of blood sugar levels, making this an alternative to insulin injections as the only existing treatment. However – donor scarcity, poor islet survival after transplant, the need to optimize the transplant site and the need for life-long immunosuppressive treatment in order to prevent transplant rejection mean this treatment is only accessible to a handful of people with T1D.
Dr. Nostro’s team will leverage their expertise in stem cell biology, vascular biology, islet transplantation and beta cell biology to address these challenges and work to develop a safe and effective clinical-grade product for therapy.
The outcome from these studies will accelerate universal donor stem cell-based T1D therapies.
Dr. Francis Lynn’s Research Team
Dr. Francis Lynn and his team will also be working towards developing a cure for T1D by replacing insulin-producing cells via transplantation.
Advances made by these research teams could not only transform the lives of thousands of Canadians living with diabetes, but also greatly reduce the tremendous economic and health burden that diabetes places on Canada today. This research may also ultimately benefit people with insulin-requiring type 2 diabetes (~30% of cases), further broadening the potential impact.
JDRF Canada is proud to support these two teams, who will carry out exciting and ambitious cell replacement research. As we approach the centenary of the discovery of insulin, we remain committed to funding research that moves beyond insulin therapy, eventually providing people with T1D freedom from their disease. This announcement is an important step in that direction.
We invited people affected by type 1 diabetes (T1D) – children, parents and researchers – to share what they wish people knew about what it means to live with this disease. Read on to learn varying perspectives of how T1D affects members of the community every single day, and what they would say to T1D with these Dear Type 1™ letters.
Myrzah, mother of Caleah
T1D has significantly changed my life as a parent. I constantly worry about the health of my daughter far more than before the diagnosis. I have more knowledge about the human body and nutrition values of food.
I feel I had to become T1D nurse overnight and become part of her support system. It is very important to have a good support system of family and friends.
People have the perception that after the diagnosis and consulting the medical team, T1D is under control. They don’t understand that it’s a daily task to maintain control. We need to accelerate the pace of T1D to give a better life quality to the people living with T1D and potentially avoid future diagnoses.
For me, a cure would mean that my daughter wouldn’t have to worry about her blood sugar levels 24h/7. She could be out with her friends without having to think about her level of activity and what she is eating etc. And of course, I would worry much less when she goes out with her friends.
My message to other parents of newly diagnosed T1D children is after the shock of the diagnosis and the overwhelming time of learning everything, it is important to accept that this condition is now part of your child’s life and family. Acceptance is key to keep going, especially on the days where we are completely discouraged.
Caleah, Diagnosed at age 8
Since my diagnosis, I have to constantly check my blood sugar levels, take note of what I eat and count carbs. I have to take care that I am not too high or too low. It is something I constantly have to take care of.
I want people to know that it’s not because I eat too much sugar or have poor health habits that I have T1D. On the contrary, we can’t prevent getting a T1D diagnosis. Our pancreas ceases to produce insulin.
Having better research and progress into T1D would facilitate our lives. And a cure would mean freedom and peace of mind. No more checking blood sugars, carb counting or worrying about my blood levels.
Having T1D does not prevent you from following your dreams. You can do whatever you want as long as you manage your T1D properly.
Fanny Guimont-Desrochers, PhD, SCYM, Immunology Research Scientist
Diagnosed at age 5
I was diagnosed with T1D when I was 5 years old. It immediately turned my life upside down. I had to prick my fingers and inject insulin multiple times a day. One could think that the injections were the worst part, but the management of the disease was way harder.
Living with T1D is like wondering at every moment of your life if your body will fail you, either because of low blood glucose level (which can cause coma if not treated), high blood glucose level or long term T1D-related complications (such as blindness, heart attack, kidney damage). This is also why I became a research scientist to help advance the cause of a T1D cure.
We need to accelerate the pace of T1D research because we are standing at a crossroads. Many promising innovations are close to becoming reality, and we need to make them available to all those who need it.
New fields of research are opening and hinting at promising potential therapies or cures that we never thought possible. Better treatments and even a cure for T1D have never been at a closer reach than they are today.
Recently, I had two safe pregnancies (without dangerous hypoglycemia) and perfectly healthy babies. Living with T1D is still a challenge I have had to live with every moment of every day for the past 30 years. That is why I am so committed to work with JDRF to cure diabetes
Helping JDRF find a cure for T1D will prevent kids other from losing their childhood. A 5-year-old kid should think about playing with his friends, not his next insulin injection. We have extremely talented scientists working on better treatments and cures. They need our help.
This exclusive group, created to provide stable funding to researchers, offers a first-time opportunity for donors to fund the research they believe in most.
Beyond Insulin™ members who make a minimum 2-year pledged commitment of $500 or more, per year, will be the first to hear about new research and treatment trials and take part in a JDRF first: the opportunity to choose, as a group, which research to accelerate.
Research is what will change lives for those living with T1D, like David. At 33-years-old, David was diagnosed with T1D. Thanks to JDRF, he had the opportunity to immediately enrol in a JDRF-funded research trial: Dr. Jan Dutz was conducting a study to see if ustekinumab, a drug that is already approved to treat other chronic diseases including Crohn’s disease, might slow the progression of T1D in people with a new diagnosis. To David’s excitement and relief, the treatment worked.
For the first two years after his diagnosis, David didn’t use insulin. This was monumental, because it slowed the pace of his diabetes and gave him valuable time to adjust to living with T1D. But the drug didn’t cure David’s T1D. After two years, he required insulin and continues to use it to manage his condition.
In 2019, JDRF invested $8.1 million into T1D research in Canada, a 5% increase over 2018. Thirty seven cutting edge projects and clinical trials were supported in Canada. Globally, 180+ new research grants were awarded for the world’s most promising studies.
Research towards a cure is accelerating at incredible speed. While a lifesaving and lifechanging treatment, we recognize that there is a need to move beyond insulin. JDRF is proud to be at the forefront of this movement.
Please consider becoming a member of Beyond Insulin. Membership will allow us to push T1D research forward faster and help to change the lives of thousands affected by T1D.
This year hasn’t been easy. As we adapt to a new way of living and shift our means of interaction virtually, we wanted to make sure we were still able to provide you with the best updates in research, education and all-things type 1 diabetes (T1D). So we launched Let’s Talk T1D!
We’re bringing experts from across the country to you with a series of virtual educational events, and community hang outs in order to help you and your loved ones live well with T1D. We want to thank everyone who has attended our events these last few months, and let you know about some more we have in the coming weeks!
Connect with your community
On the fourth Wednesday of each month, please join us in a virtual conversation for Adults and Parents in the T1D community. Here, you’ll have the ability to interact with people who have similar, lived experiences with T1D, Grow relationships with your peers and understand the ever-changing demands of living with or being affected by T1D. Click here to join one of our upcoming events!
Do you have questions about the disability tax credit (DTC) and its impact on your finances? Did you know that you can get a grant of up to 300% with a Registered Disability Savings Plan (RDSP) and you can save money for your children? Attend our Talk T1D: Education Series: T1D and Crunching the Numbers to know more about the different plans and get answers to your financial questions. Link coming soon!
We understand how important it is to have the ability to engage with those who have similar lived experiences with T1D, while educating yourselves on the latest T1D updates – and now you can do all of that from the comfort of your own home! We can’t wait to see you at our next session.
During the week of November 2nd, delegates joined JDRF for its annual Kids for a Cure Program. This year, due to COVID the event was held virtually.
Hear from some of this year’s participants:
Senator Nancy Hartling, Moncton, New Brunswick:
“Kids for a Cure was the highlight of my week. Talking to the kids and their parents and hearing their positivity gave me hope for the future and stirs me forward to keep the momentum going.
I have a personal connection to type 1 diabetes, my 8-year-old grandson who lives in BC has T1D. When I hear from the kids – I use the conversation in my speeches – it’s their voice that I want to bring forward to the government because hearing it in their words is so important.
JDRF has my commitment to write a letter to the government to supportCIHR funding – our office will be doing that, and I intend to continue speaking about it.
Across the country, access to the devices that help people manage T1D is not equal and consistent. And when all families can’t access it equally – it can be a challenge to get what they need to manage their illness. It’s even more important during COVID, as this equipment can help to keep people out of the hospital.
I want to tell all the kids and JDRF to please keep up the good work. Thank you for connecting me, I have great respect for JDRF.
I’m a very strong-minded, take-action kind of person, and I’m used to working towards solutions to my problems in my everyday life and being able to handle most things independently. But I can’t solve the problem of having diabetes by myself. No amount of hard work or dreaming big will make that happen if it’s just me. I can’t cure type one diabetes myself, as much as I want to. But Kids for a Cure is my chance to work towards a cure with dozens of other advocates living with type one diabetes who want to get rid of type one just as much as I do. And in addition to working with the other delegates, we’re also all supported and propelled forward by JDRF. JDRF gives us the platform we need in order to have our voices heard by the right people – the people who control how much funding goes into type one diabetes research. Working with JDRF and the other delegates through Kids for a Cure gives me a chance to fight for a solution to one of the biggest, most dangerous, and most heartbreaking problems in my life. Kids for a Cure to me means a fighting chance at a better future, in a way that can actually yield results.
Doing Kids for a Cure virtually had pros and cons. It was organized flawlessly and gave us (the delegates and our families) many chances to connect and plan and prepare for our MP and Senator meetings. Additionally, doing it online meant we didn’t have to go all the way to Ottawa, so it kept our schedules freer and allowed each team of delegates to have more opportunities to meet with government officials. The only con for me was that I didn’t get to meet any of the other delegates in person.
During Kids for a Cure 2018, when we all stayed in the same hotel in Ottawa, we had an incredible opportunity to be surrounded by other type one diabetics – people who understand everything it takes to manage type one diabetes in a way that only other type one diabetes can really understand. It was very special and meaningful for me, especially because I don’t have any type one diabetics in my family or my immediate circle of friends. I don’t often get the opportunity to talk to other type ones, which is isolating for me. Doing Kids for a Cure virtually still gave delegates opportunities to connect, but there was something special about all of us being in the same room, talking and laughing and being physically all together, united by our experiences and our fight for a cure.
I hope that the JDRF-CIHR Partnership to Defeat Diabetes is renewed so that we can continue to have the funding that we so desperately need if we want to move closer to a cure to type one. I also hope that the government officials with whom we met will remember us, remember our stories, and remember type one diabetes. I hope they remember our dedication, our passion, and our drive, and how hard we’ve worked to get to where we are today. Type one diabetes takes so much – mentally, physically, and emotionally – to manage and live with. We work so hard every day just to keep ourselves going, at this point without even an end to look forward to. I hope they remember us. However, they decide to show their support for us, I want us to be remembered.”
“I would like to congratulate the JDRF and its delegates for their awareness campaign, Kids for a Cure, on juvenile diabetes. Not only was this campaign a great success with participants, it was also an opportunity for the JDRF to share its hard work in research to improve the quality of life for those living with juvenile diabetes.
The two main events of this campaign, November 2nd and 3rd, also provided an opportunity for youth delegates to engage us in meaningful interactive activities to share the reality of their condition.
This reminded me and my elected colleagues of the importance of the partnership between the government and JDRF in the fight to eradicate type 1 diabetes. I applaud the impact of such awareness campaigns. As Co-Chair of the All-Party Caucus on Juvenile Diabetes, it was a great pleasure and honor for me to participate and deliver a speech. JDRF and Canadians with juvenile diabetes can always count me to be an ally.”
Terri: “This being my third time doing Kids for a Cure, it was sure different than the past.
I feel the whole atmosphere doing this in Ottawa was always amazing, and the interactions between the candidates were the best part, they got to be with so many others from all across Canada, this is where Colby and I both made amazing friends.
As for this years’ virtual Kids for a Cure, it was amazing in different ways, I believe that we had way more meetings than if we were in Ottawa, and we had great success with all our attendees making it to the meetings and I feel that we had their undivided attention. I love them interacting with the kids and asking them questions. It was a little tougher as for the internet and technology aspect but it always worked out.
While I loved all experiences we have had, I feel the better experience was the personal one in Ottawa, but as for the aspect of the MP and Senators I think they took more away from the meetings this year.
I would love to be able to do this again, it is both Colby and I passion to raise awareness.”
Colby: “First off, I have to thank everyone at JDRF for all the hard work that they do, especially to make things like kids for a cure possible. This is my third year and my favourite of all the JDRF events because we get to share our story with the people who can make a huge impact on Type1 and help us we hope find a cure.
I love chatting with the Members and I love how every time we meet with them they are always so amazed and they always seem to realize that this is a disease that affects all ages and that it is something they can get behind to make a real difference.
This year was a little different while I did seem to have a lot more meetings than before, it was kind of sad that it wasn’t that personal one on one meeting, face to face that I feel was a better impact and as well to be in the room with so many others and to meet all the delegates from across Canada is way better, sadly these times and the new way of life didn’t allow this. In the meetings virtually I do believe that there may have been more attention to the important topics and less off topic subjects, to have the scrapbooks online for them to follow as well was a huge help.
I am happy to have gotten the chance to speak to so many members and to hear them all say they will support us and they believe that it is something they will move forward with was good, and to know that by us doing this can make a lot of needed changes is also the part I like. I hope that I will get to do more things for JDRF and I want to be able to say I was a part of finding the cure.
I have been a Type1 for 7 years and from my first JDRF event I knew it was where I wanted to put my support, to know that there is a organization determined to help me and so many others living with Type1 and giving me so much hope for a cure, it was where I belonged.
It is fun to meet so many others through JDRF that live with Type1 and to know that all across Canada and the world there is so many like me struggling everyday with the same issues is a comfort.
I will always support JDRF in any capacity that will allow, and I will always encourage others to do the same. I believe that with all of us fighting the fight and JDRF on our side we will find a cure.”
Tilly would like to say: “I LOVE ‘Kids for a Cure’. It’s such an amazing experience to be part of. Meeting and connecting with other kids with Type 1 who also want to make a difference is my highlight. Advocating is a passion of mine and being able to be in front of MPs, Senators and other key decision makers is a privileged situation to be in. I’m thankful to JDRF for giving me this opportunity and for their ongoing support to the Type 1 community.”
I really felt that it was so important for each MP to hear the stories of these amazing T1D’s warriors but also the stories of the parents who care for them. The MPs that we spoke with were all very much in support of what we were asking and again it gave us hope that soon there will be a cure for this disease, hopefully in Hartley’s lifetime.
The virtual event was a huge success in my opinion. There was very little technical issues and everything was laid out on how we wanted each meeting to unfold. The only change I would have made is to be with all of the wonderful delegates in Ottawa. Fingers crossed it will happen next year.
Thank you again for all you do and if there’s anything else you need we are an open door for you.”
Thanks to the advocacy efforts of adults, parents and others touched by type 1 diabetes (T1D), the Yukon government has moved to fully reimburse continuous glucose monitoring (CGM) and flash glucose monitoring (Flash GM).
This past September, the government announced it would begin covering CGM and Flash GM for youth up to 18 years old, and Flash GM for adults, however advocates with the Yukon T1D Support Group demanded the coverage of both devices for all – regardless of age.
Meanwhile in Saskatchewan, the governing Saskatchewan Party who’ve just be re-elected have promised to reimburse CGM for those under age 25 and expand insulin pump coverage to all ages. The Opposition NDP made a similar promise, and we’ll be following up in the coming weeks to make sure it’s been fulfilled. This is great news for those with type 1 diabetes in the province. These commitments follow advocacy efforts by parent and adult advocates including the Halvorson family, who were on hand for the announcement. Hartley Halvorson, age 4 and mother Aly will be participating in this year’s Kids for a Cure Lobby Day – Home Edition.
Advocating for CGM/Flash GM funding ahead of the B.C. election
B.C. also heads to the polls in October, though a commitment to fund CGM and Flash GM was not included in party platforms – despite the fact that BC Pharmacare had been reviewing the possibility of coverage for advanced glucose monitoring systems prior to the election.
JDRF participated alongside Diabetes Canada and Type 1 Together in public and stakeholder consultations held by BC Pharmaceutical Services in August and September.
Demanding more access in Ontario
Efforts continue in Ontario to convince the government to expand access beyond Flash GM (currently covered for those under age 25, on disability or receiving social assistance who have no private insurance coverage and those over age 65). But our efforts haven’t stopped. Thanks to your support, we have produced a new pre-budget submission in October, met with officials and arranged for testimony as part of the Minister of Finance’s pre-budget consultations.
There’s still time to take action! Send an email to your provincial representative, demanding CGM and Flash GM coverage today.
Prince Edward Island resident and JDRF advocate Brooks Roche is getting vocal about #AccessForAll.
The 23-year-old young man has taken it upon himself to create an online petition asking Canadians to lobby against the government of P.E.I’s age restrictions when it comes to diabetes technology coverage.
A strong advocate for the type 1 diabetes (T1D) community, Brooks is also one of 18 members of the Prime Minister’s Youth Council — a non-partisan initiative run by the federal government.
After living with type 1 diabetes for almost two decades, he recognizes the struggles that come with the disease, and the importance of diabetes technology when managing it.
“The benefits of this are, frankly, enormous,” he said, adding that technology like insulin pumps give him peace of mind when managing his disease – taking the burden of manual injections away from him.
An insulin pump, combined with diabetes supplies can cost up to $10,000 per patient – a significant fee considering the role it plays in keeping him, and others in the T1D community alive.
“This is a chance for Prince Edward Island to lead on health policy and for us to set a standard for our neighbours to follow, rather than the other way around.” – Brooks Roche
In P.E.I, funding for insulin pumps was only available for people up to 18 years of age until recently, when the government increased funding for those up to 25 years old. Like Brooks, JDRF believes the age restriction should be lifted entirely.
Over 300,000 Canadians live with T1D, and 85% of people living with the disease are adults. Brooks believes that these age restrictions simply don’t make sense, considering the general population of those who live with T1D, and the role that diabetes technology plays in helping them manage their disease.
“This is a chance for Prince Edward Island to lead on health policy and for us to set a standard for our neighbours to follow, rather than the other way around.”
To read more about what JDRF is doing to demand #AccessForAll, click here.
People like Brooks need your help. And YOU can take action today.
Contact your provincial representative today.
Take a few minutes and send them a message now then share this action with family and friends.
Back to school includes a lot more than just a backpack, notebooks, and a pencil case. Getting back into the school routine requires a lot of preparation and planning for kids who live with type 1 diabetes (T1D)
In a perfect world, all school teachers and staff would understand how to manage T1D. Since this isn’t always the case, communication is key. It is important to meet and educate the teachers on T1D before school begins. Providing information to the school as well as classmates on T1D management, and especially recognizing the signs of hypoglycemia (low blood sugar), will help kids feel comfortable returning to school and importantly will keep them safe and healthy, no matter what the school day brings.
Here’s some information on what can cause hypoglycemia, and how to recognize the signs:
Low blood sugar can be caused by the following1:
Changes to eating patterns such as skipping or delaying a meal
More exercise or activity than usual, or exercising for a long time without eating a snack or adjusting insulin before exercise
Too much insulin or a change in the time taking insulin
Stress (tests, exams, etc.)
What are the symptoms?
Mild
Shakiness
Sweating
Dizziness
Sudden hunger
Headache
Feeling nervous
Moderate
Feeling irritated, agitated and/or confused
Lack of coordination
Difficulty speaking
Severe
Unconsciousness
Seizures or convulsions
Require help from another person
It is important always to BE PREPARED!
In case blood sugar levels fall below 4 mmol/L, school staff should be provided in advance with fast-acting glucose (e.g. Dex4 tablets, gels, and liquids). If teachers notice a difference in behaviour related to the signs of low blood sugar or children feel any of the warning signs of hypoglycemia, verify the child’s blood glucose levels immediately, and treat low blood sugar promptly if needed. In the event that a blood glucose meter is not available but low blood sugar is suspected, treat right away.
To treat, the child should eat or drink fast-acting sugar such as1:
3 teaspoons or 3 packets of table sugar dissolved in 15 ml water
3/4 cup of juice or soft drink (non diet)
1 tablespoon of honey
Afterwards, wait 15 minutes, then check blood sugar again if possible. If blood sugar cannot be tested, monitor the child closely to ensure symptoms of hypoglycemia improve. If symptoms persist and/or glucose is still below 4 mmol/L, try one of the above methods again, wait 15 minutes, and do another glucose test. If lunch is more than one hour away, provide a snack with both carbohydrates and protein.
As low blood sugar can happen at anytime, it is important to be prepared. Dex4 Glucose products help raise glucose levels FAST.
Pre-measured so you know exactly how much glucose you are consuming
Fat-Free
Caffeine, gluten, cholesterol free
Various great-tasting flavours
Additional Resources:
The JDRF Mentor Program provides one-on-one support to families and individuals living with type 1 diabetes (T1D). Trained volunteers that have experienced understand the daily challenges of living with T1D are there to provide emotional support, and connect you with resources in your local area.
1 Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Canadian Diabetes Association 2013 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada. Can J Diabetes 2013;37(suppl 1):S1-S212.
Disclaimer Information in this article is provided for informational purposes only and is not a substitute for professional medical advice.
By: Jonathan Peretz, CBRE, Senior Vice President, Managing Director and Ride Team Captain
I want to tell you a little bit about my resilient wife, Audrey.
Since the age of 13, Audrey has learned to live with type 1 diabetes (T1D), displaying patience and courage amidst countless pokes and prods, all while caring for our family and three beautiful children.
I’ve seen first-hand what it looks like to test your blood sugar upwards of 10 times a day, manually inject insulin and manage highs and lows. This is what normal looks like for her – and she does it while juggling a family and a career.
We know a cure is possible, and looking back on the medical advancements achieved last year alone, we know we’re closer than ever to finding one.
This October, the Sun Life Ride to Defeat Diabetes for JDRF is where I will be spinning, sweating or stretching for a cure for my wife, and you can join me in doing just that. Once you pick an activity that suits you best (cycling, yoga or a fitness class), you can spend an hour with your corporate peers moving for a cure.
The event will be virtual this year – meaning you can make a massive impact on the lives of those living with type 1 diabetes all while staying safe at home.
Help us raise critical funds for ground-breaking research. My wife’s life has changed for the better over the last 22 years…just think about what more we can accomplish together in the next 22!
We can’t thank you enough for your support. Let’s turn type one into type none together.
